期刊文献+

应用荧光定量PCR和Western-blot检测RNA干扰肺腺癌A549细胞STAT3基因表达水平的实验研究

EXPERIMENTAL STUDY OF RNA IN TERFERENCE INHIBITING STAT3 GENE EXPRESSION IN LUNG ADENO CARCINOMA A549 CELLS BY FIUORESCENCE QUANTITATIVE PCR AND WESTERN-BLOT
下载PDF
导出
摘要 目的:研究RNAi技术对人肺腺癌A549细胞系中STAT3基因的阻断效应,探讨STAT3在肺癌中的重要作用,为肺癌的基因治疗寻找新的靶点。方法:将化学合成siRNA用脂质体介导法转染肺腺癌A549细胞,应用荧光定量PCR法检测RNA干扰后STAT3 mRNA表达量,得出抑制率。应用Western-blot检测RNA干扰后对STAT3蛋白表达的影响。结果:成功将siRNA转染肺腺癌A549细胞,荧光定量PCR结果显示,在转染24h、48h、72h后,各干扰组与阴性组比较STAT3基因表达量明显下调(P<0.05),Western blot显示转染前后STAT3蛋白的表达水平明显受到抑制,干扰组与阴性组空白组相比具有显著差异(P<0.05),内参基因在各组的表达量无明显差异。结论:将合成的STAT3 siRNA能有效抑制STAT3蛋白的表达、降低STAT3 mRNA水平,对STAT3有高效和特异的沉默作用,以STAT3为靶点的RNA干扰技术可望成为肺癌基因治疗的新策略。 Objective:To study blocking effects of RNAi technology on STAT3 expression in lung adeno carcinoma A549 cells..Methods: After liposome-mediated siRNA transfection of A549 cells,the expression of STAT3mRNA was determined by fluorenscence quantitative PCR,STAT3 protein expression was detected by Western-blot Results:lung adenocarcinoma A549 cells ware Successfully transfected with siRNA.Fluorescence quantitative PCR results showed that after transfected 24h,48h,72h,the interference group STAT3 gene expression was significantly reduced(P〈0.05),Western-blot resnlt showed that STAT3 protein expression was significantly inhibited in interference group(P〈0.05).Conclusion: The synthetic STAT3siRNA can effectively inhibit the expression of STAT3 protein and lower the levels of STAT3.mRNA of STAT3.It has an efficient and specific silencing effect to STAT3.RNA interference technology with STAT3 as target is expected to become a new strategy for gene therapy of lung cancer.
出处 《泸州医学院学报》 2010年第5期498-502,共5页 Journal of Luzhou Medical College
基金 四川省科技厅重点资助基金项目(2006J13-192)
关键词 肺癌:RNA干扰 STAT3 基因治疗 Lung cancer RNA interference STAT3 gene therapy
  • 相关文献

参考文献4

二级参考文献34

  • 1王鸿程,李艳萍,李万成,陈洁.肺腺癌细胞增殖分化及抗凋亡作用与STAT3的调控效应[J].中国临床康复,2005,9(14):128-129. 被引量:3
  • 2王鸿程,许学亮,曹乃清,孔智斌,陈洁,简丽萍.STAT3、Bcl-xL、Bax和CyclinD1在非小细胞肺癌中的表达[J].细胞与分子免疫学杂志,2007,23(4):341-342. 被引量:18
  • 3Bownan T, Gatcia R, Turkson J, et al. STATs in oncogenesis[J]. Oncogene, 2000, 19(21 ): 2474-2488.
  • 4Fu M, Wang C, Li Z, et al. Minireview: Cyclin D1 : normal and abnormal functions[J]. Endocrinology, 2004, 145(12): 5439-5447.
  • 5Huang M, Page C, Reynolds RK, et al. Constitutive activation of star 3 oncogene product in human ovarian carcinoma cells [ J ]. Gynecol Oncol, 2000, 79 ( 1 ) : 67 - 73.
  • 6Alas S, Bonavida B. Rituximab inactivates signal transducer and activation of transcription 3 ( STAT3 ) activity in B-non-Hodgkin' s lymphoma through inhibition of the interleukin 10 autocrine/paracrine loop and results in down-regulation of Bcl-2 and sensitization to cytotoxic drugs[J]. Cancer Res, 2001, 61(13): 5137-5144.
  • 7Weiss JM, Nath A, Major EO, et al. HIV-1 Tat induces monocyte chemoattractant protein-l-mediated monocyte transmigration across a model of the human blood-brain barrier and up-regulates CCR5 expression on human monocytes[ J]. J Immunol, 1999,163 ( 5 ) :2953-2959.
  • 8Bowman T, Garcia R, Turkson J, et al. STATs in oncogenesis[J]. Oncogene, 2000, 19(21) :2474-2488.
  • 9Grandis JR, Drenning SD, Zeng Q, et al. Constitutive activation of STAT3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo [ J ]. Proc Natl Acad Sci USA, 2000, 97 (8):4227 -4232.
  • 10Schuringa JJ, Wierenga AT, Knfijer W, et al. Constitutive STAT3,Tyr705, and Ser727 phosphorylation in acute myeloid leukemia cells caused by the autocrine secretion of interleukin-6 [ J ].Blood, 2000, 95(12) :3765-3770.

共引文献37

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部